Navigation Links
The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009'
Date:12/2/2009

LEXINGTON, Mass. and HEIDELBERG, Germany, Dec. 2 /PRNewswire/ -- febit's HybSelect has been recognized as one of the winners of the "Top 10 Innovations of 2009" by The Scientist magazine. The company's automated sequence capture technology for high-throughput sequencing was selected due to its exceptional combinations of invention, vision and utility.

The Scientist gathered a panel of expert judges to evaluate a broad range of life science technologies and determined the best innovations to hit the life sciences market in 2009. The winners' list includes a variety of products that capture both intracellular and extracellular processes. HybSelect is a robust and automated method for selecting and enriching high-value target regions from the genome that enables cost-effective massively parallel sequencing.

"Next-Generation-Sequencing (NGS) is an accurate and high-performance technology for diagnostics and has been limited by throughput, cost, data management and automation issues," said Peer Staehler, chief scientific officer of febit. "Instead of analyzing large-sequence stretches of a single genome, researchers using HybSelect are now able to focus on targeted re-sequencing of interesting regions from many different patients in parallel."

HybSelect combines the advantages of microarray-based enrichment with patent protected microfluidic biochip technology and runs on the dedicated, highly automated instrument, the Geniom® RT Analyzer. It allows to conduct large scale clinical studies to identify SNPs and mutations as new biomarkers to receive statistically relevant data.

To read the full article of The Scientist please visit http://www.the-scientist.com/2009/12/1/41/1/

About febit

febit develops, produces and markets flexible automated solutions for enabling biochip applications in Life Sciences. febit's product portfolio includes various instruments, optimized assays and bioanalytical services, complemented by bioinformatics software and consulting.

The key applications are HybSelect, febit's innovative DNA capture method for Next-Generation-Sequencing, and hands-off, amplification free microRNA profiling. Both are taking advantage of the advanced microfluidics of the patented Geniom Biochip to offer the highest degree of automation, flexibility and efficiency available.

For more information, please visit www.febit.com.


          Contact: febit group, Eva Sterzel, eva.sterzel@febit.de,
                              +49 (0)6221 6510-300
                     Russo Partners, Martina Schwarzkopf,
         martina.schwarzkopf@russopartnersllc.com, +1 212 845-4292

SOURCE febit


'/>"/>
SOURCE febit
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Two Hutchinson Center Scientists Receive a Total of $16.7 Million for Collaborative Stem Cell Research
2. Roche Scientist Recognized for Excellence in Peptide Chemistry
3. New Cardiovascular Biomarker Available for Scientist in North America
4. Scientists Identify Gene for Short Circuiting Excess Mucous in Lung Disease, Common Colds
5. IBM Scientists First to Image the Anatomy of a Molecule
6. Scientists Discover Origin of Malaria
7. International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit
8. Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy
9. Scientists Discover a Role for the Growth Factor TGF-beta in Maintaining Health of Retinal Blood Vessels
10. Scientists Discover Why Teeth Form in a Single Row
11. Scientists Unmask Genetic Markers Associated With Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
(Date:9/22/2017)... ROCKVILLE, Md. , Sept. 22, 2017  As ... by Republican Senators Bill Cassidy (R-LA) and ... Kalorama Information notes that the medical device industry is ... the medical device tax, the 2.3% excise tax on ... Act.  But they also want covered patients, increased visits ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
Breaking Medicine Technology:
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
Breaking Medicine News(10 mins):